Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Incrocci

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Radiobiological Modeling for Acute Proctitis After Conventional and Hypofractionated Radiation Therapy for Prostate CancerChristian A M Jongen, Ben J M Heijmen, Luca Incrocci, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
A quality control model that uses PTV-rectal distances to predict the lowest achievable rectum dose, improves IMRT planning for patients with prostate cancerYibing Wang, Andras Zolnay, Luca Incrocci, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2019
Role of the DNA damage response in prostate cancer formation, progression and treatmentWenhao Zhang, Dik C van Gent, Luca Incrocci, et al.
JCO Global Oncology|August 8, 2022
Clinicopathology and Treatment Patterns of Head and Neck Cancers in EthiopiaAdugna Fekadu, Tara J Rick, Wondemagegnhu Tigeneh, et al.
Prostate Cancer and Prostatic Diseases|July 19, 2019
Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatmentWenhao Zhang, Dik C van Gent, Luca Incrocci, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2018
Moderate Hypofractionation in Intermediate- and High-Risk, Localized Prostate Cancer: Health-Related Quality of Life From the Randomized, Phase 3 HYPRO TrialRuud C Wortel, Esther Oomen-de Hoop, Wilma D Heemsbergen, et al.
Frontiers in Oncology|December 20, 2021
Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in AfricaWilliam Swanson, Richard Ndi Samba, Michael Lavelle, et al.
Cancers|January 8, 2025
Added Value of Biological Effective Dose in Dosiomics-Based Modelling of Late Rectal Bleeding in Prostate CancerChristian A M Jongen, Wilma D Heemsbergen, Luca Incrocci, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2020
Ethiopia: How the Care of 100 Million People Pivots on a Single Cobalt Teletherapy MachineTara J Rick, Biruk Habtamu, Aynalem Abreha, et al.
International Journal of Clinical Oncology|August 16, 2008
Cardiac metastasesAbrahim Al-Mamgani, Lizette Baartman, Margreet Baaijens, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Radiobiological Modeling for Acute Proctitis After Conventional and Hypofractionated Radiation Therapy for Prostate CancerChristian A M Jongen, Ben J M Heijmen, Luca Incrocci, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
A quality control model that uses PTV-rectal distances to predict the lowest achievable rectum dose, improves IMRT planning for patients with prostate cancerYibing Wang, Andras Zolnay, Luca Incrocci, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2019
Role of the DNA damage response in prostate cancer formation, progression and treatmentWenhao Zhang, Dik C van Gent, Luca Incrocci, et al.
JCO Global Oncology|August 8, 2022
Clinicopathology and Treatment Patterns of Head and Neck Cancers in EthiopiaAdugna Fekadu, Tara J Rick, Wondemagegnhu Tigeneh, et al.
Prostate Cancer and Prostatic Diseases|July 19, 2019
Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatmentWenhao Zhang, Dik C van Gent, Luca Incrocci, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2018
Moderate Hypofractionation in Intermediate- and High-Risk, Localized Prostate Cancer: Health-Related Quality of Life From the Randomized, Phase 3 HYPRO TrialRuud C Wortel, Esther Oomen-de Hoop, Wilma D Heemsbergen, et al.
Frontiers in Oncology|December 20, 2021
Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in AfricaWilliam Swanson, Richard Ndi Samba, Michael Lavelle, et al.
Cancers|January 8, 2025
Added Value of Biological Effective Dose in Dosiomics-Based Modelling of Late Rectal Bleeding in Prostate CancerChristian A M Jongen, Wilma D Heemsbergen, Luca Incrocci, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2020
Ethiopia: How the Care of 100 Million People Pivots on a Single Cobalt Teletherapy MachineTara J Rick, Biruk Habtamu, Aynalem Abreha, et al.
International Journal of Clinical Oncology|August 16, 2008
Cardiac metastasesAbrahim Al-Mamgani, Lizette Baartman, Margreet Baaijens, et al.
Pageof 15